Description

Pharmacogenomics is a key enabler of personalised pharmacotherapy, helping clinicians and pharmacists tailor treatment according to a patient’s genetic profile to improve effectiveness, reduce adverse drug reactions, and optimise outcomes across therapeutic areas. The Pharmacogenomics and Personalised Pharmacotherapy Special Interest Group (PGxPP SIG) brings together ESCP members who wish to advance the responsible, practical integration of pharmacogenomic testing into clinical pharmacy practice across Europe.

Aims

  • Build a European network for case discussion, experience sharing, and collaboration in pharmacogenomics and personalised pharmacotherapy.
  • Strengthen professional competence through knowledge exchange and peer support focused on real-world application.
  • Support clinical integration by sharing approaches for embedding pharmacogenomic information into therapeutic decision-making and clinical workflows.
  • Raise awareness among healthcare professionals, patients, and the public about pharmacogenomics and its implications for safer, more effective care.
  • Catalyse research and funding opportunities by monitoring relevant calls and fostering collaborative grant applications, implementation projects and multi-centre initiatives within the ESCP community.
  • Promote education and workforce readiness by supporting the integration of pharmacogenomics into undergraduate and postgraduate pharmacy curricula across Europe.

Establishment

The PGxPP SIG was launched in Grenoble in 2025 in response to the limited and slow implementation of pharmacogenomic testing in clinical practice. Additionally, establishment of the PGxPP SIG aims to strengthen the leadership role of clinical pharmacists in pharmacogenomics by fostering a collaborative network for sharing practical experience, supporting implementation, and advancing education, thereby promoting broader and more consistent adoption of pharmacogenomics within clinical pharmacy practice across Europe.

Steering Committee

Prof. Francesca Wirth (Chair)

Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Malta

Dr. Natalia Stollarova

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovakia

Prof. Samuel Allemann

Department of Pharmaceutical Sciences, University of Basel, Switzerland

Prof. Michael Scott

Medicines Optimisation Innovation Centre (MOIC), Antrim Area Hospital, Northern Ireland

Dr. Joanne Brown

Senior research and innovation programme manager, Medicines Optimisation Innovation Centre, Northern Ireland. Honorary Senior Lecturer Queen’s University, Belfast

Join this SIG

How to reach and collaborate with SIG Pharmacogenomics and Personalised Pharmacotherapy?

Contact SIG Pharmacogenomics and Personalised Pharmacotherapy via e-mail: sig.pgx@escpweb.org or send your application via the members section of the ESCP website: Click here for the application form.

ESCP Members can fill in an application form for the respective SIG via the forms available on this page Click here for the application form.